Electrochemical and paper based biosensing platforms using nucleic acids as bioreceptors
Health
Prototype
Description
Electrochemical and paper based biosensors that use synthetic nucleic acids to detect either proteins or DNA that are sensitive and specific to the target analyte that can be used as point of care screening for diagnosis of various diseases.
Impact
Improving access to sensitive and specific diagnostic screening devices that can quantify the concentration of target analyte which facilitates early screening of diseases hence supporting clinicians to initiate timely treatment of patients.
Target Audience
Regional referral hospitals and patients accessing diagnostic services in regions outside Kampala
Industrial Value Chains
Pathogen Economy (vaccines, diagnostics, therapeutics)
Partnerships
Individual (self-led or personal innovation)
Innovation Details
Stage:
Prototype
Funding Status:
Funded
Location:
Kampala
Innovation Date:
September 3, 2023
Contact Information
Related Innovations
Egessa Hand Washing Facilities
Egessa Bwire Richard • 1 month ago
Aquavault
Cornelius Chen-Chen • 1 month ago
Multi-gym access platform
MUDUULI DAVID • 1 month ago